Sphingosine 1-phosphate-driven interplay between neutrophils and endometriotic cells fuels fibrosis in endometriosis: insights into the role of neutrophil extracellular traps

In: Journal of Translational Medicine · 2026 · doi:10.1186/s12967-026-08971-9 · W7212161686
article OA: gold CC0
AI-generated summary by qwen3.7-flash, 2026-09-13

Sphingosine 1-phosphate drives a bidirectional crosstalk between neutrophils and endometriotic cells that fuels fibrosis in endometriosis by promoting neutrophil extracellular trap formation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-13 · read from full text

This study investigated the molecular mechanisms linking neutrophil extracellular traps (NETs) to fibrosis in endometriosis, utilizing patient-derived lesions and cultured endometriotic cells. The researchers identified a bidirectional crosstalk driven by sphingosine 1-phosphate (S1P), where endometriotic cells stimulate neutrophils to release NETs, which in turn induce epithelial-mesenchymal transition and collagen deposition in endometriotic tissue. Key findings demonstrated that silencing S1P biosynthesis or transport enzymes abrogated this pro-fibrotic effect, highlighting the pathway as a potential non-hormonal therapeutic target. This paper is centrally about endometriosis — specifically the role of neutrophil extracellular traps and S1P signaling in driving fibrotic progression within ectopic endometrial lesions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Background Endometriosis is a chronic disease affecting millions of women worldwide, characterized by the presence of ectopic endometrial-like tissue. While the formation of neutrophil extracellular traps (NETs) has been linked to endometriosis progression, the underlying implicated molecular mechanisms remain poorly understood. Methods The presence of NETs was evaluated using immunofluorescence and the extent of fibrosis was assessed using Masson’s trichrome staining in patient endometriotic lesions ( n = 10) in comparison with the endometrium of healthy women ( n = 10). Human epithelial and stromal endometriotic cells were used to evaluate the fibrotic effect of NETs. The involvement of the signaling of sphingosine 1-phosphate (S1P) in the fibrotic effect of NETs was assessed by genetic and pharmacologic approaches. Conditioned media from endometriotic cells where S1P metabolism or export were modulated, were employed to evaluate their effect on neutrophil NETosis. The plasma levels of the NET marker (MPO) and S1P were measured in patients ( n = 30) and controls ( n = 20). Results Immunofluorescence and immunohistochemistry analysis of patient-derived lesions revealed a significant increase in NET markers and collagen deposition compared to controls. NET treatment induced epithelial-mesenchymal transition and fibrosis in endometriotic epithelial as well as stromal cells. Mechanistically, in endometriotic cells NETs modulated the S1P signaling axis by increasing the expression of sphingosine kinase-1 (SK1), one of the two isoforms responsible for S1P biosynthesis, the S1P transporter Spns2, and S1P 2 and S1P 3 receptors. Notably, the pro-fibrotic effect of NETs was abrogated when SK1 or Spns2 were specifically silenced. To add further layers of complexity, conditioned media from endometriotic cells where S1P metabolism or export were modulated, potently influenced neutrophil NETosis demonstrating that endometriotic cells stimulated neutrophils to release NETs via S1P, creating a pathological feedback loop. The relevance of the S1P/NET axis in endometriosis was supported by the positive correlation between S1P and MPO plasma levels in patients but not in healthy controls. Conclusions Our findings identify a novel S1P-driven bidirectional crosstalk between neutrophils and endometriotic cells that fuels the progression of fibrosis. These results highlight the S1P signaling pathway as a promising non-hormonal therapeutic target for the treatment of endometriosis since interfering with S1P metabolism and export could be extremely beneficial not only for counteracting fibrogenesis but also NETosis.
Full text 6,758 characters · extracted from oa-html · 5 sections · click to expand

Abstract

Background Endometriosis is a chronic disease affecting millions of women worldwide, characterized by the presence of ectopic endometrial-like tissue. While the formation of neutrophil extracellular traps (NETs) has been linked to endometriosis progression, the underlying implicated molecular mechanisms remain poorly understood.

Methods

The presence of NETs was evaluated using immunofluorescence and the extent of fibrosis was assessed using Masson’s trichrome staining in patient endometriotic lesions (n = 10) in comparison with the endometrium of healthy women (n = 10). Human epithelial and stromal endometriotic cells were used to evaluate the fibrotic effect of NETs. The involvement of the signaling of sphingosine 1-phosphate (S1P) in the fibrotic effect of NETs was assessed by genetic and pharmacologic approaches. Conditioned media from endometriotic cells where S1P metabolism or export were modulated, were employed to evaluate their effect on neutrophil NETosis. The plasma levels of the NET marker (MPO) and S1P were measured in patients (n = 30) and controls (n = 20).

Results

Immunofluorescence and immunohistochemistry analysis of patient-derived lesions revealed a significant increase in NET markers and collagen deposition compared to controls. NET treatment induced epithelial-mesenchymal transition and fibrosis in endometriotic epithelial as well as stromal cells. Mechanistically, in endometriotic cells NETs modulated the S1P signaling axis by increasing the expression of sphingosine kinase-1 (SK1), one of the two isoforms responsible for S1P biosynthesis, the S1P transporter Spns2, and S1P2 and S1P3 receptors. Notably, the pro-fibrotic effect of NETs was abrogated when SK1 or Spns2 were specifically silenced. To add further layers of complexity, conditioned media from endometriotic cells where S1P metabolism or export were modulated, potently influenced neutrophil NETosis demonstrating that endometriotic cells stimulated neutrophils to release NETs via S1P, creating a pathological feedback loop. The relevance of the S1P/NET axis in endometriosis was supported by the positive correlation between S1P and MPO plasma levels in patients but not in healthy controls.

Conclusions

Our findings identify a novel S1P-driven bidirectional crosstalk between neutrophils and endometriotic cells that fuels the progression of fibrosis. These results highlight the S1P signaling pathway as a promising non-hormonal therapeutic target for the treatment of endometriosis since interfering with S1P metabolism and export could be extremely beneficial not only for counteracting fibrogenesis but also NETosis. Similar content being viewed by others Abbreviations - BSA: - Bovine serum albumin - CIB1: - Calcium integrin binding protein 1 - citH3: - citrullinated histone H3 - CM: - Conditioned medium - DMEM: - Dulbecco’s modified eagle medium - E-CAD: - E-caderin - EEC: - Endometriotic epithelial cells - EMT: - Epithelial–mesenchymal transition - ESC: - Immortalized human stromal endometriotic cells - F12: - Nutrient mixture f-12 ham - FBS: - Fetal bovine serum - FN: - Fibronectin - GAPDH: - Glyceraldehyde-3-phosphate dehydrogenase - IF: - Immunofluorescence analysis - IHC: - Immunohistochemistry - IS: - Internal standard (IS) - LC-MS/MS: - Liquid chromatography tandem-mass spectrometry - MPO: - Myeloperoxidase - MTT: - 3-[4,5-dimethylthiazol–2-yl]-2,5-diphenyltetrazolium bromide) - NE: - Neutrophilic elastase - NETs: - Neutrophil extracellular traps - PBS: - Phosphate buffer solution - PMA: - Phorbol-12-myristate-13-acetate - RA: - Retinoic acid - S1P: - Sphingosine 1-phosphate - S1PR: - Sphingosine 1-phosphate receptor - SK: - Sphingosine kinase - SPL: - S1P lyase - SPP: - S1P phosphatase - Spns2: - Spinster homolog 2 - TGLN: - Transgelin - αSMA: - αsmooth muscle actin

Acknowledgements

We took advantage of the newly established Molecular Medicine Facility of the Department of Experimental and Clinical Biomedical Sciences “Mario Serio” at the University of Florence. The Facility was supported by a grant from the Italian Ministry of Education University and Research (MIUR) after the Department was awarded as one of the 180 Departments of Excellence in Italy. This paper is dedicated to the memory of our co-author, Prof. Asgerally T. Fazleabas, who passed away after the resubmission of the revised version of this manuscript. We are deeply grateful for his invaluable dedication to this project. Funding The work was supported by Fondi di Ateneo (ex 60%) to C.B., C.D. and F.P., by PRIN 2022 PNRR D.D. 1409 14/9/2022 National Recovery and Resilience Plan, Mission 4—Component 2, Investment 1.1 funded by the European Union—NextGeneration EU—CUP_B53D23024590001 to C.B. and C.G., by Fondo di Beneficenza Intesa Sanpaolo to C.B. Author information Authors and Affiliations Corresponding author Ethics declarations Ethics approval and consent to participate The study was conducted under the approval of Institutional Review Board (number 13742), and in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information Below is the link to the electronic supplementary material. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. About this article Cite this article Prisinzano, M., Seidita, I., Bertilacchi, M.S. et al. Sphingosine 1-phosphate-driven interplay between neutrophils and endometriotic cells fuels fibrosis in endometriosis: insights into the role of neutrophil extracellular traps. J Transl Med (2026). https://doi.org/10.1186/s12967-026-08971-9 Received: Accepted: Published: DOI: https://doi.org/10.1186/s12967-026-08971-9

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-21T06:00:58.944781+00:00
License: CC0 · commercial use OK